Pancreas Transplantation in Korea

At a Glance

Overview

Pancreas transplantation replaces a diseased or non-functional pancreas with a healthy donor organ, restoring the body's ability to produce insulin independently. It is primarily indicated for patients with Type 1 diabetes mellitus (T1DM) who experience severe glycemic instability or life-threatening hypoglycemia that cannot be controlled by insulin therapy alone.

Three main procedural variants are performed in South Korea:

• Simultaneous Pancreas-Kidney (SPK): A pancreas and kidney from the same deceased donor are transplanted in a single operation. This is the most common approach, suited for T1DM patients who also have diabetic nephropathy or end-stage renal disease.
• Pancreas After Kidney (PAK): A pancreas transplant performed after a prior kidney transplant, for patients who have already received or will receive a kidney from a living donor.
• Pancreas Transplant Alone (PTA): For patients with adequate kidney function but severe metabolic complications of diabetes.

A fourth option available at select Korean centers is living-donor segmental pancreas transplantation, where the distal body and tail of a living donor's pancreas are transplanted. This approach enables better HLA matching and shorter ischemia time compared to deceased-donor transplants.

South Korea has developed significant institutional expertise in all four approaches, supported by national registries, government-regulated organ allocation infrastructure, and high-volume transplant centers that have collectively performed hundreds of cases over multiple decades.

Am I a Candidate?

Not every patient with diabetes is a candidate. Transplant teams at Korean centers use rigorous multidisciplinary evaluation to determine suitability.

Typical indications for evaluation include:

• Type 1 diabetes mellitus with hypoglycemia unawareness, frequent severe hypoglycemic episodes, or consistently uncontrolled blood glucose despite optimal insulin therapy
• Diabetic nephropathy with declining kidney function (eGFR typically below 20 mL/min), making SPK the preferred route
• Intolerable quality-of-life impact from insulin-dependent diabetes
• Patients who have already received a kidney transplant and seek metabolic correction (PAK pathway)

Patients are generally excluded or require careful case-by-case review if they have:

• Significant cardiovascular disease that elevates surgical risk
• Active malignancy or uncontrolled infection
• Severe obesity (BMI thresholds vary by center)
• Substance use disorders or documented non-adherence to medical regimens
• Advanced age with multiple comorbidities, though age alone is not an absolute barrier

Foreign patients seeking evaluation in Korea typically undergo pre-arrival consultations, with medical records translated and reviewed by the transplant team. KONOS registration is required for deceased-donor waitlisting, and timelines for international patients vary. Living-donor transplants from a compatible family member can sometimes reduce waiting time significantly.

How the Procedure Works

All pancreas transplants in Korea are performed under general anesthesia in a major surgical facility with dedicated organ transplant teams including transplant surgeons, anesthesiologists, perfusionists, and intensive care specialists.

The general sequence for an SPK procedure:

• Pre-operative preparation: Final crossmatch testing, immunosuppression induction (typically with anti-thymocyte globulin or basiliximab), cardiac clearance, and bowel preparation.
• Organ procurement and cold preservation: The donor pancreas (and kidney in SPK) are procured by a separate surgical team and preserved in cold storage solution. Cold ischemia time is carefully minimized, as longer ischemia is associated with poorer graft function.
• Recipient surgery: The recipient's abdomen is opened via a midline incision. The donor pancreas is typically placed in the right iliac fossa, with vascular anastomoses connecting donor vessels to the recipient's iliac artery and vein. Exocrine drainage is handled by anastomosing the donor duodenal segment either to the recipient's small bowel (enteric drainage, the more widely used approach) or to the bladder.
• Kidney implantation (SPK): The donor kidney is placed in the left iliac fossa in the same operation, with separate vascular and ureteral anastomoses.
• Closure and ICU transfer: The abdomen is closed and the patient transferred to an intensive care or high-dependency unit for close monitoring.

For living-donor segmental pancreas transplant, only the distal pancreas (body and tail) is harvested from the donor, who retains the head of the pancreas. The donor undergoes a separate simultaneous surgery, and both procedures are coordinated by the same transplant team.

This approach is practiced at high-volume Korean centers with demonstrated experience in living-donor abdominal organ programs.

Recovery Timeline

Recovery from pancreas transplantation is extended and requires sustained medical supervision. Korean transplant centers typically plan for international patients to remain in-country for a minimum of 8 to 12 weeks after surgery.

Phase-by-phase timeline:

• ICU / step-down (Days 1–7): Intensive monitoring of graft function, blood glucose levels, fluid balance, and early signs of rejection or surgical complications such as thrombosis, bleeding, or anastomotic leak.
• General ward (Days 7–21): Transition to oral immunosuppression (typically a tacrolimus + mycophenolate mofetil + corticosteroid regimen), gradual dietary advancement, patient and caregiver education on medication adherence and self-monitoring.
• Hospital discharge to local accommodation (Weeks 3–5): Most uncomplicated SPK patients are discharged to nearby serviced accommodation. Outpatient visits occur 2–3 times per week for labs, tacrolimus level checks, and clinical assessment.
• Weeks 5–12 in Korea: Continued close follow-up, with decreasing visit frequency as labs stabilize. Biopsy may be performed if rejection is suspected.
• Return home (from ~Week 10–12): Coordination with the patient's home care team is established. Korean transplant coordinators provide detailed discharge summaries and immunosuppression protocols.
• Months 3–6: Gradual functional recovery, return to daily activities. Insulin requirements typically drop to zero in successful SPK and PTA recipients within days to weeks of a functioning graft.
• Long-term: Lifelong immunosuppression, annual follow-up, and metabolic monitoring. Rejection episodes requiring treatment can occur years after transplant.

Cost Breakdown

Pancreas transplantation in South Korea is generally estimated to cost $80,000–$150,000 USD for the full surgical episode, depending on the procedure type, hospital tier, length of stay, and complications.

This range covers the surgical procedure, operating room, anesthesia, organ procurement and preservation, immediate ICU and ward stay, and initial immunosuppression supply. It does not typically cover pre-travel evaluation, international flights, long-term accommodation, or ongoing immunosuppression medication costs after discharge.

SPK procedures are generally at the higher end of the range due to the dual-organ complexity and longer operative time. PTA may be lower if the patient has no kidney disease and a shorter hospital admission is achieved.

Korea's cost advantage relative to the United States — where pancreas transplant episodes can run considerably higher — is supported by lower hospital overhead, government-regulated transplant infrastructure, and efficient high-volume surgical teams.

Medical Korea, the government-backed portal operated by KHIDI (Korea Health Industry Development Institute), provides a framework for international patients to access registered hospitals. Facilities working within this system are subject to quality accreditation standards set by the Korean government.

Patients should request itemized cost estimates from the transplant center before travel and confirm what post-discharge medications and follow-up visits are included in quoted packages.

Why Korea

South Korea has built one of Asia's most comprehensive solid organ transplantation programs, underpinned by government infrastructure, national registries, and high procedural volumes at specialist centers.

KONOS (Korean Network for Organ Sharing), established under the Act on Organ Transplantation (2000), manages deceased-donor organ procurement, recipient matching, and allocation across the country. This centralized system ensures regulated, transparent, and equitable organ distribution — a critical quality-of-care factor for international patients.

KOTRY (Korean Organ Transplantation Registry), initiated in 2014, tracks outcomes for all solid organ transplant recipients nationally, enabling continuous quality improvement and providing a documented evidence base for survival and graft function rates.

Korea's transplant programs have particular depth in pancreas transplantation for Type 1 diabetes. High-volume centers have published outcomes showing 1-year and 5-year death-censored pancreas graft survival rates comparable to leading programs worldwide.

The availability of living-donor segmental pancreas transplant — less commonly offered outside specialized Asian centers — provides an additional pathway for eligible patients.

KHIDI and the Medical Korea portal actively support international patients through registered hospital networks, coordinator services, and visa facilitation specifically for medical travelers. Korea's healthcare system combines nationally accredited hospital quality with costs that are significantly lower than equivalent care in North America or Western Europe.

The concentration of transplant expertise in a small number of high-volume centers, rather than dispersal across many low-volume hospitals, supports the consistent team experience that complex procedures like SPK require.

Related Topics

Sources

• Outcomes of pancreas transplantation over two decades — PMC 2025
• Strategies for Monitoring and Supporting Living Donors in Korea — PMC 2025
• Medical Korea — Transplantation (KHIDI official portal)
• Medical tourism in South Korea — Wikipedia

Top Hospitals